List of companies in CTI Life Sciences Fund's investment portfolio
Name | Description | Industry | Official Website | Location | ||
|---|---|---|---|---|---|---|
A company developing antibody-based biological medicines for kidney diseases and other chronic diseases. Visterra was acquired by Otsuka Pharmaceutical in 2018. | ||||||
A biopharmaceutical company discovering and developing small molecules that target G protein-coupled receptors | ||||||
A company focused on the development on therapeutic antibodies and other protein-based therapeutics | ||||||
SutroVax is an independent vaccine platform in California that focuses on delivering conjugate vaccines and complex antigen-based vaccines to prevent deadly infectious diseases. | ||||||
Phenomic AI is a Toronto-based company. | ||||||
Epitopea is a RNA-based immunotherapies developer to treat cancer patients founded in 2021 by Jon Moore, Claude Perreault and Pierre Thibault. | ||||||
PHEMI is a new class of data warehouse that uses big data technologies to handle any volume and variety of data. | ||||||
PreciThera, Inc. is a biotech company that is positioned to develop therapies for bone diseases. | ||||||
Visterra is a company founded by Ram Sasisekharan. | ||||||
A molecular diagnostics company that develops testing for infecctious diseases | ||||||
Glycomine is an early-stage biotech working on replacement therapies for rare diseases. | ||||||
Ability Pharma is a first-in-class causing autophagy molecules founded in 2009. | ||||||
CellAegis Devices is a healthcare company. |
